Geron Corporation (BIT:1GERN)
Italy flag Italy · Delayed Price · Currency is EUR
1.205
0.00 (0.00%)
At close: Jul 18, 2025

Geron Company Description

Geron Corporation, a commercial-stage biopharmaceutical company, focuses on the development of therapeutics products for oncology.

It offers RYTELO a telomerase inhibitor for the treatment f adult patients with low- to intermediate-1 risk myelodysplastic syndromes with transfusion-dependent anemia.

The company was incorporated in 1990 and is headquartered in Foster City, California.

Geron Corporation
CountryUnited States
Founded1990
IndustryBiological Products, Except Diagnostic Substances
Employees229
CEODawn Bir

Contact Details

Address:
919 East Hillsdale Boulevard
Foster City, Delaware 94404
United States
Phone650 473 7700
Websitegeron.com

Stock Details

Ticker Symbol1GERN
ExchangeBorsa Italiana
Stock TypeCommon Stock
Fiscal YearJanuary - December
Reporting CurrencyUSD
SIC Code2836

Key Executives

NamePosition
Dawn BirChief Executive Officer
Michelle RobertsonChief Financial Officer
Andrew GrethleinChief Operating Officer
Aron FeingoldHead of Investor Relations